Lynx Biosciences
PrivateLast Round
Seed
Nov 3, 2021
Total Funding Raised
$2.4M
Company Overview
Lynx Biosciences operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Seed round in November 2021.
Lynx Biosciences is a biotechnology company that offers a proprietary ex vivo disease biology platform for drug discovery and development in immuno-oncology and immunology.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lynx Biosciences Comparables
Compare Lynx Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kiyatec | 82% | |
| CanChip GmbH | 75% | |
| Merck | 71% |
For institutional investors. Book with your work email.
Lynx Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 3, 2021 | ||||
| Seed | Mar 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Lynx Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Great Oaks Venture Capital | Seed |
| WARF Ventures | Seed |
| Cove Fund | Seed |
| Checkmate Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 3, 2021
Led by Checkmate Capital with participation from Cove Fund, Great Oaks, and WARF Ventures.
For institutional investors. Book with your work email.
Lynx Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lynx Biosciences's valuation, stock price, and market status.
Is Lynx Biosciences a public or private company?
Lynx Biosciences is a private company.
What is the current stock price of Lynx Biosciences?
Lynx Biosciences is a private company, so its shares have no public market price. Caplight tracks Lynx Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lynx Biosciences worth (valuation)?
Valuation information for Lynx Biosciences is not publicly available.
Can I buy Lynx Biosciences stock?
Lynx Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lynx Biosciences's last funding round?
Lynx Biosciences's most recent funding round was Seed on November 3, 2021.
Who are the main investors in Lynx Biosciences?
Key investors in Lynx Biosciences include Cove Fund, Checkmate Capital.
Will Lynx Biosciences IPO soon?
No public IPO plans have been announced for Lynx Biosciences.
How can I track Lynx Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Lynx Biosciences's shares on secondary markets.